DSIP stands for Delta Sleep-Inducing Peptide, named after its discovery in animals entering deep slow-wave (delta) sleep
conducted a 12 week facial study on 67 women and reported that GHK-Cu cream applied twice daily improved aged skin appearance, increased thickness, reduced wrinkles and strongly stimulated skin cell growth
The standard cagrilintide monotherapy titration follows this schedule: 0.25 mg weekly for weeks 1-4, then 0.5 mg for weeks 5-8, then 1.0 mg for weeks 9-12, then 1.7 mg for weeks 13-16, and finally 2.4 mg for week 17 onward as the maintenance dose
Slow injection may minimize any stinging sensation associated with the compound
Key findings include enhanced phosphorylation of Src, Caveolin-1, and eNOS, with the vasodilation effect being abolished by nitric oxide inhibitors